Clinical Data earns milestone; NanoViricides raises cash;

> Santen Pharmaceutical has filed for approval of Clinical Data's ATL313 for primary open angle glaucoma and ocular hypertension, triggering a $2 million milestone payment to Clinical Data which is due by January 15, 2011. Clinical Data release

> The FDA has rejected Cumberland Pharma's attempt to expand the label on its liver drug Acetadote. Report

> Sanofi-Aventis has bought the rights to a diabetes drug-delivery technology from Ascendis, an American and Danish pharmaceutical company. Sanofi says in a news release that the technology showed "promising results" with insulin in early tests. Story

> REVA closes $63M Aussie IPO. News

> MagForce looks to tackle solid tumors. Article

> When you slurp on your favorite sweet gelatin treat at a holiday party this season (with, or without floating pineapple chunks), think about how that gel you're eating is a liquid rendered solid by, according to AAAS Science Now, "a more or less rigid but disordered network of microscopic particles dispersed throughout its volume." Report

And Finally... A little genetic tinkering led to an unusual creation at the University of Osaka. Scientists developed a line of mice that can sing like a bird. Report

Suggested Articles

Almirall and Iktos will use the latter's AI technology to design new compounds that tick multiple drug criteria boxes.

Pfizer’s 2017 spinout company SpringWorks has lost president and founder Lara Sullivan, M.D., who has moved over to Pyxis Oncology as its new chief.

In this week's EuroBiotech Report, Sanofi inks $2.5B Synthorx takeover and posts sutimlimab data, Roche shares bispecific results and more.